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Abstract
In both septic and aseptic inflammation, N-formyl peptides may enter the circulation and
induce a systemic inflammatory response syndrome similar to that observed during septic
shock. The inflammatory response is brought about by the binding of N-formyl peptide to
formyl peptide receptors (FPRs), specific signaling receptors expressed on myeloid as well
as non-myeloid cells involved in the inflammatory process. N-formyl peptides conjugated
with fluorochromes, such as fluorescein isothiocyanate (FITC) are increasingly experimen-
tally used to identify tissues involved in inflammation. Hypothesizing that the process of
FITC-conjugation may transfer formyl peptide to a ligand that is efficiently cleared from the
circulation by the natural powerful hepatic scavenging regime we studied the biodistribution
of intravenously administered FITC-fNLPNTL (Fluorescein-isothiocyanate- N-Formyl-Nle-
Leu-Phe-Nle-Tyr-Lys) in mice. Our findings can be summarized as follows: i) In contrast to
unconjugated fNLPNTL, FITC-fNLPNTL was rapidly taken up in the liver; ii) Mouse and
human liver sinusoidal endothelial cells (LSECs) and hepatocytes express formyl peptide
receptor 1 (FRP1) on both mRNA (PCR) and protein (Western blot) levels; iii) Immunohis-
tochemistry showed that mouse and human liver sections expressed FRP1 in LSECs and
hepatocytes; and iv) Uptake of FITC-fNLPNTL could be largely blocked in mouse and
human hepatocytes by surplus-unconjugated fNLPNTL, thereby suggesting that the hepa-
tocytes in both species recognized FITC-fNLPNTL and fNLPNTL as indistinguishable
ligands. This was in contrast to the mouse and human LSECs, in which the uptake of FITC-
fNLPNTL was mediated by both FRP1 and a scavenger receptor, specifically expressed on
LSECs. Based on these results we conclude that a significant proportion of FITC-fNLPNTL
is taken up in LSECs via a scavenger receptor naturally expressed in these cells. This calls
for great caution when using FITC-fNLPNTL and other chromogen-conjugated formyl pep-
tides as a probe to identify cells in a liver engaged in inflammation. Moreover, our finding
emphasizes the role of the liver as an important neutralizer of otherwise strong inflammatory
signals such as formyl peptides.
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Introduction
To maintain homeostasis, the animal body is equipped with a powerful system of hepatic scav-
enger cells that remove circulating waste that otherwise might represent potential harm to the
cells of the body. In this context, waste represents foreign stimuli such as microbial-derived
macromolecules but also endogenous molecules that are released into circulation due to cell
death or cell injury.
Innate immune responses in liver cells rely on the expression of pattern recognition recep-
tors (PRRs) that recognize pathogen-associated molecular patterns, PAMPs, or endogenous
molecules that are able to cause damage, referred to as damage-associated molecular patterns,
DAMPs [1, 2]. The PAMPs are conserved molecular motifs found in microbial pathogens,
which include viral nucleic acids and various bacteria-derived molecules. On the other hand,
DAMPs represent non-microbial danger signals composed of host molecules often released
by necrotic cells in the context of tissue damage. Both PAMPS and DAMPS trigger innate
immune signaling and promote inflammation [2, 3].
Several types of PRRs are expressed in the liver. Most important are the endocytic mannose
receptor and stabilins present on liver sinusoidal endothelial cells (LSECs) [1], which are uti-
lized by LSECs to remove an array of circulating PAMPs and DAMPs. The LSEC expresses
other important PRRs, including several toll-like receptors [4–6].
Mitochondria are organelles thought to arise from a symbiotic relationship with a host cell.
Thus, the release of mitochondrial components such as DNA or N-formyl peptides may trigger
strong inflammatory responses. Upon bacterial infection, as well as tissue injury, N-formyl
peptides may enter the circulation and cause induction of systemic inflammatory response syn-
drome similar to that observed during septic shock [7, 8].
Therefore, it is of the utmost importance that these potentially dangerous macromolecules
be efficiently removed from the blood circulation.
N-formyl peptide acts as typical PAMPs/DAMPs that can attract leukocytes to the sites of
infection or tissue damage [9]. Formyl peptide receptor 1 (FPR1) is a cell surface PRR that
binds and is activated by N-formyl-peptides originally described in leukocytes, which are
important for the induction of inflammation and immune cell activation. More recently, FPR1
has also been detected in cells of non-myeloid origin such as glial cells, endocrine cells of the
thyroid and adrenal glands, smooth muscle cells and lens epithelial cells, hence indicating the
involvement of the receptor in a wide variety of both inflammatory and immunological
responses [10, 11].
Intravenously administered formyl peptides conjugated with fluorescein isothiocyanate
(FITC) or other fluorochrome are increasingly used as a probe to identify cells and tissue involved
in inflammation [12–15]. The rationale for this is that fluorochrome-labeled formyl peptides will
target cells that express FPR1. Knowing that conjugation with FITC increases the hepatic clear-
ance of biomolecules [16] we found it pertinent to determine to what extent conjugation with
FITC transform formyl peptide into a ligand for the natural hepatic clearance mechanisms.
For this reason, in the present study we chose to use N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys
(fNLPNTL) (Fig 1) and found that blood borne FITC-fNLPNTL, but not unconjugated
fNLPNTL is rapidly taken up in mouse liver, with a high uptake in both isolated LSECs and
liver parenchymal cells (hepatocytes). In addition, studies were carried out with human liver
and isolated human LSECs and hepatocytes to determine to what extent the findings with the
mouse model translated to human liver and liver cells. Our results show that intravenously
administered FITC-fNLPNTL is taken up to a great extent in normal liver and liver cells via
natural LSEC-specific scavenger receptors, and hence must be used with great caution if the
purpose is to identify sites of inflammation.
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Materials and Methods
Reagents
Collagenase was fromWorthington Biochemical Corporation (Lakewood, NJ), and Liberase™
(collagenase) from Roche Applied Science (Oslo, Norway). Iodogen™ was from Pierce Chemi-
cals (Rockford, IL), and carrier-free Na125I from PerkinElmer Norge AS (Oslo, Norway).
Bovine serum albumin was fromMP Biomedicals (Solon, OH), and bovine collagen type I
(Vitrogen 100) from Cohesion Technologies (Palo Alto, CA). Human fibronectin purified
from human plasma by affinity chromatography on Gelatin Sepharose 4B was a kind gift from
Dr. Peter McCourt. Percoll™ and PD-10 columns (Sephadex G-25) were purchased from GE
Healthcare (Uppsala, Sweden). Roswell Park Memorial Institute (RPMI) 1640 cell culture
medium (supplemented with 20 mM sodium bicarbonate, 0.006% penicillin, and 0.01% strep-
tomycin) was from Sigma-Aldrich (St Louis, MO). Human endothelial serum-free basal
medium (HESFM) was obtained from Life Technologies. Vascular endothelial growth factor
(VEGF) and hepatocyte growth factor (HGF) were from Peprotech, Germany. Falcon cell cul-
ture plates were from BD Biosciences (San Jose, CA), and Permanox chamber slides from
VWR, Norway. N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys (fNLPNTL) was purchased from
Fig 1. Structure of the peptides used in the study.Chemical structure and molecular mass of fNLPNTL (A)
and FITC-fNLPNTL (B).
doi:10.1371/journal.pone.0160602.g001
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Phoenix Pharmaceuticals (Burlingame, CA, USA), and its fluorescein isothiocyanate derivative
(FITC-fNLPNTL) from Thermo Scientific (Oslo, Norway).
Formaldehyde-treated bovine serum albumin (FSA) was prepared as described [17].
Polyclonal rabbit anti-FPR1 (H-230-Santa Cruz Biotech), rat-anti mouse CD206, clone
MCA2235 (AbD Serotec, Oxford, UK), goat anti-human CD206 (R&D Systems), Alexa Fluor1-
488 and -594 conjugated secondary antibodies (InVitrogen), and Draq5 (BioStatus Limited,
Leicestershire, UK) were used for immunolabeling of cells and tissue.
Ethics Statement
All animal experiments were approved by the Norwegian National Animal Research Authority
(NARA) (approval IDs: ID-4689; ID-6688). The substances used for mouse anesthesia were a
combination of tiletamine hydrochloride (Zoletil forte vet, Virbac, Norway), xylazine (Rom-
pun, Bayer Nordic, Norway) and fentanyl (Actavis, Norway) (ZRF).
Human liver tissue was obtained from patients undergoing hepatic resections for colorectal
cancer carried out at The National Hospital, Oslo, Norway. The patients participating in this
study provided their signed consent after reading the information form. These signed docu-
ments were brought to our laboratory along with the liver resections from each individual
patient who had agreed to participate. Same documents are filed along with other lab protocol
documents in our laboratory. The Regional Committee for Medical and Health Research Ethics
in North Norway approved this consent procedure (reference number 2011/686).
Animals
Wild-type C57BL/6 male mice were obtained from the Charles River Laboratory, France. The
animals were housed in rooms specially designed for mice, with 12 h/12 h day-night cycle, and
free access to water and food (standard chow, Scanbur BK, Nittedal, Norway).
Labeling procedures
Unconjugated fNLPNTL and FITC- fNLPNTL were reconstituted at a concentration of 4
mg/ml in DMSO. Twenty μl of the solution, corresponding to 100 μg of each peptide was fur-
ther diluted in PBS to a final volume of 200 μl and incubated with carrier-free Na125I for 1h
at RT, using Iodogen as described by the manufacturer. The labeled peptides were separated
from unbound 125I by elution with PBS through PD-10 columns. The specific radioactivities
were 0.98 x 106 cpm/μg and 0.12 x 106 cpm/μg for 125I-FITC-fNLPNTL and 125I-fNLPNTL,
respectively.
Anatomical distribution of radiolabeled peptides
Prior to experiments, mice were weighed and pre-warmed in a temperature controlled cham-
ber to stimulate dilation of the tail veins. Trace amounts of 125I-FITC-fNLPNTL or 125I-
fNLPNTL (8 μg in 137 μl PBS) were i.v. injected in non-anesthetized mice. The mice were anes-
thetized immediately after the i.v. injection by intraperitoneally injection of the ZRF mixture,
followed by another intraperitoneal injection of a 1/3 dose of ZRF, 20 min later. Thirty min
after i.v. administration of the peptides, a blood sample of 5 μl was collected from the tip of the
tail using pre-calibrated glass pipettes. The abdominal cavity was opened and the body was
cleared of blood and free radio-tracer from the vasculature by systemic perfusion through the
heart with PBS. Internal organs and parts of the body were collected in pre-weighed test tubes:
liver, spleen, kidneys, stomach, intestines, urinary bladder including urine, lungs, heart, muscle,
head, tail, and the rest of the carcass. The amount of radioactivity was measured in all organs
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and in the blood sample. The radioactivity per total volume of blood was calculated considering
that the average amount of blood in a mouse is approximately 58.5 ml per kg of bodyweight
(according to the National Centre for the Replacement Refinement & Reduction of Animals in
Research). The amount of tracer recovered was the sum of radioactivity of individual organs,
carcass and the radioactivity calculated in total blood volume.
Hepatocytes (Heps) and sinusoidal endothelial cells (LSECs) isolation
from mouse and human liver
Mouse Heps (mHeps) and LSECs (mLSECs) were prepared by collagenase (Liberase) perfusion
of mouse livers, followed by a low-speed differential centrifugation to separate Heps, and den-
sity sedimentation of the non-Heps enriched in the supernatant, on 25%– 45% Percoll gradi-
ents to collect LSECs and Kupffer cells (KCs), as described [18]. Mouse LSECs were obtained
after a panning step of 8 min at 37°C to remove KCs. The purity of mLSECs was between 90
and 95% as judged by fenestration assessed by scanning electron microscopy and positive
immunostaining for the LSEC specific marker, stabilin 2. The remaining 5–10% of cells in
these cultures represented KCs/monocytes and stellate cells.
Human hepatocytes (hHeps) and LSECs (hLSECs) were isolated from encapsulated liver
resections based on a method described elsewhere [19]. The procedure involves collagenase
perfusion through cut blood vessels exposed on the surface of the liver resection. hHeps were
isolated by low speed differential centrifugation, and the hLSECs purified by immunomagnetic
isolation using mouse anti-human CD32 (Fitzgeralg Industries International INC, North
Acton, MA, USA) and Dynabeads1 Sheep anti-mouse IgG (Thermo Scientific, Oslo, Norway).
The viability of hLSECs as judged by trypan blue exclusion was 95%, and the yield of hLSECs
varied from 1 to 10 million depending on the size of the liver resection. The purity of the
hLSECs isolation was between 85 and 95%, as judged by light microscopy. This variation in
purity is due to donor variation.
Primary mouse and human liver cell cultures were established on glass cover slides pre-
coated with collagen type I and human fibronectin, respectively. Heps cultures were maintained
inWilliam’s E supplemented with antibiotics, glutamine, HEPES, insulin and dexamethasone,
mLSECs in serum-free RPMI-1640 medium, and hLSECs in HESFM supplemented with antibi-
otics, 10% FCS, 10 ng/ml VEGF and 10 ng/ml HGF. Cultures of Heps and LSECs were incu-
bated in 20% O2 or 5% O2, respectively.
Immunohistochemistry
Liver tissue was embedded in Tissue-Tek OCT Compound (Sakura Finetek, Staufen, Ger-
many), snap-frozen in liquid nitrogen, cut on a cryostat and stored at -80°C until use.
Sections were fixed with cold acetone for 10 min, washed 3X in PBS and then incubated with
anti-FPR1 antibody. For co-localization immunostaining, mouse and human liver tissue sec-
tions were incubated overnight at 4°C with a primary anti-CD206 (Mannose receptor) antibody
for the identification of LSECs and with anti-FPR1 antibody. For fluorescence visualization,
anti-rabbit Alexa Fluor1-488, anti-rat Alexa Fluor1-594 or anti-goat Alexa Fluor1-594 were
used. A matched isotype was also used as a control for nonspecific background staining. Images
were taken on Zeiss LSM 780 microscope using the same acquisition settings for all sections.
Immunocytochemistry
Primary cultures of mouse and human Heps and LSECs on Permanox chamber slides coated
with human fibronectin were starved by 4 h of pre-incubation in a serum-free culture medium,
and then challenged with 20 μg/ml FITC-fNLPNTL in serum-free culture medium for 1h at
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37°C. The cells were extensively washed with PBS to remove unbound ligands and fixed with
4% PFA for 30 min prior to immunostaining. Non-specific binding was blocked by incubating
the cells for 60 min at RT with 1% bovine serum albumin (BSA) in Tris-buffered saline with
Tween (TBST). This was followed by 1h of incubation at 37°C with primary antibody (1:200)
and then washed with TBST and incubated with Alexa Fluor1-488 conjugated goat anti-rabbit
(1:1000) for 60 min at RT. For negative controls, isotype IgGs (same concentration as primary
antibodies) or secondary antibodies only were used instead of the primary antibody. Nuclei
were stained with a solution of 1:1000 Draq5 in PBS. The liver sections were then mounted with
Dako Fluorescent Mounting Medium (Dako) and covered with glass coverslips. Images were
taken using a confocal laser scanning microscopy (Zeiss LSM 780 microscope; Zeiss, Germany).
Endocytosis competition of FITC-fNLPNTL by mouse and human Heps
and LSECs
Primary cultures of mouse and human Heps and LSECs were seeded on Permanox chamber
slides coated with human fibronectin. Following 4 h of serum-free starvation, the cells were
incubated for 60 min at 37°C with 20 μg/ml of FITC-fNLPNTL in a serum-free culture
medium, in the presence or absence of 100 μg/ml of native, non-FITC, fNLPNTL and FSA.
The cells were pre-incubated with fNLPNTL or FSA for 30 min prior to the addition of the
FITC-fNLPNTL. After removal of unbound ligand by extensive washing with PBS, the cultures
were fixed with 4% PFA and processed for fluorescence microscopy as described above.
RNA isolation
Total RNA was isolated from pelleted cells and whole tissue using the Qiagen RNeasy Mini Kit
(QiagenHilden, Germany) according to the manufacturer's protocol. The quantity and quality
of the extracted RNA was determined by the use of a spectrophotometer NanoDrop ND-1000
(Wilmington, DE, USA). cDNA was synthesized from 1 μg of total RNA using the QuantiTect
Reverse Transcription Kit (Qiagen) according to the manufacturer's protocol.
Quantitative PCR assay
PCR was performed in a 25 μl reaction mixture containing 2 μl of cDNA (from isolated RNA),
12.5 μl of the JumpStart REDTaq1 Ready Mix (Sigma-Aldrich), 0.5 μl of 10 μM forward and
reverse primers, and 9.5 μl of ddH2O. The reactions were performed in a BioRad T-100 thermal
cycler with the following conditions: initial denaturation at 95°C for 2 min, denaturation at
95°C for 30 sec, annealing at 58°C for 30 sec and extension at 72°C for 2 min. In total, 35 cycles
were conducted with a final extension at 72°C for 10 min. PCR products were electrophoresed
on 2% agarose gel and visualized under UV light. The sequences of PCR primers were human
FPR1 forward: 5’-TGCCCTGGCCTTCTTCAACAGC-3’; and reverse: 5’-CGGGAAGGGCGT
GGATCAGC-3’(PrimerBank ID 36951095c1, http://pga.mgh.harvard.edu/primerbank/index.
html); human STAB2 forward: 5’-GTGCCCGGATGGTTACACC-3’; and reverse: 5’-CTTC
CTACAAATATGGCGGCAT-3’ (PrimerBank ID 61743979c1); human CRP forward: 5’-
TCGTATGCCACCAAGAGACAAGACA-3’; and reverse: 5’-AACACTTCGCCTTGCACTTCA
TACT-3’; human β-actin forward: 5’-CTCGACACCAGGGCGTTAT-3’; and reverse: 5’-
CCACTCCATGCTCGATAGGAT-3’; mouse FPR1 forward: 5’-ACAGCCTGTACTTTCGAC-
3’; and reverse: 5’-CTGGAAGTTAGAGCCCGTTC-3’; mouse STAB2 forward: 5’-AGCT
GCTGCCTTTAATCCTCA-3’; and reverse: 5’-ACTCCGTCTTGATGGTTAGAGTA-3’ (Pri-
merBank ID 20149764a1); mouse GAPDH forward: 5’- ACCACAGTCCATGCCATCAC -3’;
and reverse: 5’- TCCACCACCCTGTTGCTGTA -3’.
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Western blot analysis
Homogenized tissue specimens and cells were lysed directly in a RIPA lysis buffer (Pierce Bio-
technology, Rockford, IL, USA) with both a protease inhibitor cocktail (Roche Applied Science,
Basel, Switzerland) and Halt phosphatase inhibitor cocktail (Pierce Biotechnology). A mixture
containing NuPAGE LDS Sample Buffer, NuPAGE Sample Reducing Agent (Life Technolo-
gies, Carlsbad, CA, USA) and distilled water were added to lysates. The samples were heated to
70°C for 10 min, and equal amounts of protein were loaded into a NuPAGE Novex 4–12% Bis-
Tris gel (Life Technologies). Gel electrophoresis and blotting onto a PVDF membrane (Life
Technologies) were performed according to the NuPAGE Technical Guide (Invitrogen). Tris
buffered saline with 0.1% Tween-20 (Sigma Aldrich) and 5% Bio-Rad Blotting-grade blocker
(Bio-Rad, Hercules, CA, USA) were used for blocking, while primary and secondary antibodies
were diluted in the blocking buffer. Membranes were probed with antibodies against FPR1 and
β-actin (both from Abcam, Cambridge, UK) and concentrations of the antibodies were 1:500
and 1:5000 respectively. Goat Anti-Rabbit IgG H&L (HRP) antibodies (Abcam, Cambridge,
UK) at a 1:5000 dilution were used as secondary antibodies. SuperSignal West Pico Chemilu-
minescent Substrate (Pierce-Thermo scientific, Rockford, IL) was used for detection, and
images were acquired on a Fujifilm LAS-3000 Imager.
Results
Anatomical distribution of intravenously injected 125I-fNLPNTL
Native fNLPNTL and FITC-conjugated fNLPNTL (FITC- fNLPNTL) were labeled with 125I
and intravenously injected into mice to assess their anatomical distribution. Analysis of organs
30 min post injection revealed that the liver was the major organ of uptake of both native and
FITC- fNLPNTL (Fig 2). Of note, the uptake of 125I-FITC-fNLPNTL in the liver was three-fold
Fig 2. Anatomical distribution of i.v. administered fNLPNTL. The anatomical distribution of radio-labeled peptides was performed in C57BL/6
mice dosed i.v. with 8 μg of 125I-FITC-fNLPNTL (gray bars) or 125I-fNLPNTL (blue bars). Thirty min post-injection, the vasculature was washed free of
blood and blood-borne radio-tracer by systemic perfusion through the heart. Blood, internal organs and carcass were harvested and analyzed for
radioactivity. Data (n = 2 per group) represent the percentage of radioactivity counted in each organ, total blood and carcass, in relation to the total
radioactivity recovered.
doi:10.1371/journal.pone.0160602.g002
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higher compared to that of native fNLPNTL. This finding was accompanied by higher amounts
of native fNLPNTL in the blood and rest of the carcass, thus suggesting a slower blood clear-
ance of the native fNLPNTL compared to FITC-fNLPNTL.
Expression of FPR1 in liver tissue and cells
Formyl peptide receptor 1 (FPR1) is a broadly expressed receptor with pattern recognition
properties involved in diverse biological events. To investigate wether the uptake of the formyl
peptide in the liver was mediated by FPR1, we determined the expression of FPR1 in isolated
liver cells and tissue. In addition, we challenged mouse and human liver cell cultures with
FITC-fNLPNTL and assessed the uptake by fluorescence microscopy.
FPR1 expression in LSECs was performed by RT-PCR analysis using specific primers for
murine and human FPR1. The cDNA detected by gel electrophoresis indicates the presence of
FPR1 transcripts in both human and mouse Heps and LSECs (Fig 3A). Stabilin 2 and CRP
were used as LSEC and Heps specific markers, respectively (not shown). Western blot analyses
of tissue and cell lysates confirmed the PCR results (Fig 3B).
Immunohistochemistry of human and mouse liver tissue, and on isolated Heps and LSECs,
revealed positive staining for FPR1. In murine liver, the staining was mainly observed in the
cells lining the sinusoids (Fig 4A), while in human liver the staining was more evenly localized
to both sinusoidal cells and Heps (Fig 4B). Double immunofluorescence staining using an anti-
Fig 3. Expression of FPR1mRNA and protein in liver and isolated liver cells. (A) Total RNAwas isolated
from pelleted cells and whole tissue. cDNA was synthesized from 1 μg of total RNA using the QuantiTect
Reverse Transcription Kit. PCR was performed in a 25 μl reaction mixture containing 2 μl of cDNA of hHeps
(1), hLSECs (2), human liver (3), mHeps (4), mLSECs (5), andmouse liver (6). The house keeping genes were
β-actin and GAPDH. (B) Homogenized tissue specimens and cells were lysed in a RIPA lysis buffer with
protease and phosphatase inhibitor cocktails. Equal amounts of protein were loaded into NuPAGENovex
4–12%Bis-Tris gel, then blotted onto PVDFmembrane and probed with antibodies against FPR1 and β-actin.
doi:10.1371/journal.pone.0160602.g003
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FPR1 antibody and an anti-mannose receptor (CD206:MR) antibody, an LSEC marker [20],
demonstrated that the FPR1 is expressed by LSECs. FPR1 was also detected on isolated hHeps
and hLSECs in primary cultures, as shown by immunofluorescence (Fig 5).
Characterization of binding specificity
The involvement of FPR1 in the uptake of formyl peptide in different human and murine liver
cells was investigated by incubating cultured LSECs and Heps with trace amounts of FITC-
fNLPNTL in the presence or absence of excess concentrations of native fNLPNTL (Fig 6). We
found that the inhibitory effect of native peptide was modest in LSECs, but apparently com-
plete in Heps, suggesting that Heps took up FITC-fNLPNTL by the same mechanism as uncon-
jugated fNLPNTL, whereas the uptake of FITC-fNLPNTL could be only partially inhibited by
excess fNLPNTL.
To further investigate this we incubated LSECs with FITC-fNLPNTL only, or in the pres-
ence of formaldehyde-treated-serum-albumin (FSA), a ligand known to be specifically endocy-
tosed by the LSECs scavenger receptors (Fig 7). These studies revealed that the uptake of FITC-
fNLPNTL was inhibited by the presence of FSA in both human and murine LSECs, although to
a higher extent in hLSECs (Fig 7C and 7D). This difference may be due to the much higher
endocytic activity of freshly isolated mLSECs compared to hLSECs, which have been cultured
for five days prior to the experiment.
Fig 4. Immunohistochemical analysis of expression of FPR1 in human andmouse liver tissue. Liver sections were fixed with cold acetone for 10
min, washed in PBS and incubated overnight at 4°C with polyclonal rabbit anti-FPR1 (1:200), followed by Alexa Fluor1-488 goat anti-rabbit (1:1000).
Intense FPR1 staining can be observed along the sinusoids in mouse liver (A), while in human liver the staining was more evenly localized to both LSECs
and Heps (B). Double staining was performed using polyclonal rabbit anti-FPR1, rat anti-mouse CD206, and goat anti-human CD206, followed by Alexa
Fluor1-488 and Alexa Fluor1-594 secondary antibodies, respectively.
doi:10.1371/journal.pone.0160602.g004
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Discussion
The liver sinusoidal endothelial cell (LSEC) represents a unique class of endothelial cells dis-
tinct from the other classes of endothelial cells in the body [21]. Functionally, this cell type has
an endocytic machinery capable of very efficient uptake and degradation of physiological and
foreign waste material, including all major classes of biological macromolecules and nanoparti-
cles (< 200 nm) [22]. The endocytic capacity of LSECs greatly exceeds that of other types of
endothelial cells. The signature feature of LSECs as scavenger cells, responsible for the removal
of potentially dangerous macromolecules from blood, emphasizes their importance in liver
immunity.
Formyl peptides labeled with FITC or other fluorochromes are increasingly used to identify
cells involved in inflammatory reactions since it is generally believed that this probe, when
administered i.v., will effectively target cells that carry the receptor for formyl peptides, FPR1, in
the same way as unconjugated fNLPNTL. We found it important to verify this hypothesis, and
devised a series of experiments to study whether FITC-fNLPNTL exhibits the same in vivo dis-
tribution pattern as fNLPNTL. In order to trace the injected ligand, the fNLPNTL was radioio-
dinated by two distinct features, through labeling the FITC group of the FITC-fNLPNTL
conjugate or directly to a tyrosine group within fNLPNTL.
First, we investigated the fate of fNLPNTL administered i.v. into mice. Interestingly, FITC-
fNLPNTL was taken up in the liver to a much greater extent than was fNLPNTL. Moreover,
the unconjugated peptide distributed to blood and carcass to a much higher extent than its
FITC-labeled counterpart (Fig 2).
Fig 5. Immunocytochemical analysis of expression of FPR1 in isolated human liver cells. Primary cultures of hHeps (A) and LSECs (B) fixed with
4% PFA were stained for FPR1 using polyclonal rabbit anti-FPR1 (1:200) and Alexa Fluor1-532goat anti-rabbit (1:1000). Isotype IgGs (same
concentration as primary antibodies), or secondary antibodies only were used as negative controls. Nuclei were stained with Draq5 in PBS (1:1000).
Zeiss LSM 780 confocal laser scanning microscope was used for picture acquisition.
doi:10.1371/journal.pone.0160602.g005
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We next wanted to identify the receptors involved in the uptake of the conjugated and
unconjugated peptides. First, we established that FPR1, on both mRNA and protein basis was
present in the liver and isolated liver cells of mice and humans. Subsequent immunohistochem-
istry on mouse- and human liver sections showed that FPR1 was present in LSECs and Heps,
with a higher expression in mouse LSECs. The coincident staining of mannose receptor and
FPR1 in sinusoidal cells suggested that the receptor protein was expressed in LSECs. Immunocy-
tochemistry on isolated human liver cells showed the expression of FPR1 in both LSECs and
Heps. The finding that excess unconjugated fNLPNTL blocked the uptake of FITC-fNLPNTL in
mouse and human Heps showed that these cells did not distinguish between the two ligands.
This is a strong indication that conjugation with FITC does not change the recognition of the
peptide in Heps. The same type of ligand-receptor competition experiments in isolated LSECs
showed that excess unconjugated fNLPNTL only partly inhibited the uptake of FITC-fNLPNTL.
We interpret this to mean that LSECs use at least one more type of receptors in addition to
FPR1 in their uptake of FITC-fNLPNTL. Hence, the dramatic increase in vivo of hepatic clear-
ance of fNLPNTL after FITC conjugation is attributable to increased LSECs uptake. To deter-
mine whether this other receptor might be the “work horse” scavenger receptor of LSECs,
namely the LSEC-specific scavenger receptor, or stabilin 1/2, we incubated isolated murine and
human LSECs with FITC-fNLPNTL in the presence or absence of formaldehyde-modified
serum albumin (FSA), a ligand that is frequently used to study specific stabilin-mediated endo-
cytosis in LSECs [23]. The observation that FSA inhibited the uptake of FITC-fNLPNTL in both
Fig 6. Ability of native fNLPNTL to compete with FITC-fNLPNTL for uptake in culturedmurine and human LSECs and hepatocytes. Cultures of
mHeps (A), mLSECs (B), hHeps (E), and hLSECs (F) were serum starved and incubated for 60 min at 37°C with 20 μg/ml of FITC-fNLPNTL in the
presence or absence of 100 μg/ml of native fNLPNTL. After the removal of unbound ligands by extensive washing with PBS, the cultures were fixed with
4% PFA and processed for fluorescence microscopy. Uptake of FITC-fNLPNTL in mHeps (C) and hHeps (G) was blocked by native fNLPNTL, while a
less marked effect was seen in mLSECs (D) and hLSECs (H).
doi:10.1371/journal.pone.0160602.g006
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human and mouse LSECs strongly suggests that these scavenger cells use stabilin to clear FITC-
fNLPNTL from the circulation.
It has been previously reported that FITC labeling of proteins drastically shorten their
serum half-lives, causing their rapid clearance in the liver [16]. On this background we
Fig 7. Competitive effect of FSA on FITC-fNLPNTL uptake by human andmurine LSECs. Primary cultures of hLSECs (A) and
mLSECs (B) were established on Permanox chamber slides coated with human fibronectin. Following 4 h of serum-free starvation, the
cells were incubated for 60 min at 37°C with 20 μg/ml of FITC-fNLPNTL in a serum-free culture medium, in the presence or absence of
100 μg/ml of FSA. After removal of unbound ligands by extensive washing with PBS, the cultures were fixed with 4% PFA and
processed for fluorescence microscopy. Uptake of FITC-fNLPNTL was inhibited by the presence of FSA in hLSECs (C) to a higher
extent than seen in mLSECs (D).
doi:10.1371/journal.pone.0160602.g007
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hypothesized that FITC labeling may have the same liver targeting effect on fNLPNTL. An
increased net negative charge of proteins resulting from occupying positively charged lysyl
residues by conjugation with fluorescein via the isothiocyanate group leads to an increased
uptake in LSECs [24]. In conclusion, our finding emphasizes the role of LSECs as important
neutralizers of otherwise strong inflammatory signals such as formyl peptides associated with
both DAMPS and PAMPS.
Importantly, conjugated flurochromes such as FITC-fNLPNTL must be used with great cau-
tion in systemic studies on the biodistribution of fNLPNTL since a considerable proportion of
an injected dose of FITC-fNLPNTL will end up in the powerful LSEC scavenger cells through a
mechanism that is caused by FITC conjugation. This could give a false impression of presence
and location of inflammatory cells in the liver.
Supporting Information
S1 Fig. Complete WBmembranes and PCR gels images for Fig 3. (A) Complete PCR gel rep-
resenting human data for Fig 3. Lanes 1, 2 and 3 correspond to hHeps, hLSECs and human
liver respectively. Lanes 4 are no template controls. (B) Complete PCR gel representing mouse
data for Fig 3. Lanes 1, 2 and 3 correspond to mHeps, mLSECs and mouse liver respectively.
Lanes 4 are no template controls. (C) WB membrane representing human data for Fig 3. Lanes
1, 2 and 3 correspond to hHeps, hLSECs and human liver respectively. (D) WBmembrane rep-
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